Navigation Links
Ascenta Therapeutics Announces Multiple Presentations on AT-101 at 2009 ASCO Annual Meeting
Date:5/26/2009

MALVERN, Pa., May 26 /PRNewswire/ -- Ascenta Therapeutics announced today that eleven presentations or publications on pre-clinical and clinical studies of AT-101, an oral, pan-Bcl-2 inhibitor, in several major tumor types will be made during the 2009 American Society of Clinical Oncology (ASCO) Annual Meeting, May 29-June 2, in Orlando, Florida. Abstracts are available at www.asco.org.

(Logo: http://www.newscom.com/cgi-bin/prnh/20090227/PH75873LOGO )

Prostate Cancer

MacVicar G, et al. An open-label, multicenter, phase I/II study of AT-101 in combination with docetaxel (D) and prednisone (P) in men with castrate resistant prostate cancer (CRPC). Abstract #5062; Poster Board #17; Poster Discussion, May 31, 8:00 a.m.-12:00 p.m.

Poiesz B, et al. Preliminary report of an open-label, multicenter, phase I/II study of AT-101 in combination with docetaxel (D) and prednisone (P) in men with docetaxel refractory prostate cancer. Abstract #5145; Poster Board #J13; GU General Poster Session, May 31, 2:00 p.m.-6:00 p.m.

Glioma

Fiveash J, et al. NABT-0702: A phase II study of AT-101 in recurrent glioblastoma multiforme (GBM). Abstract #2010; Poster Board #2; Poster Discussion, May 30, 8:00 a.m.-12:00 p.m.

Lung Cancer

Heist R, et al. A phase I/II study of AT-101 in combination with topotecan (T) in patients with relapsed or refractory small cell lung cancer (SCLC) after prior platinum containing first line chemotherapy. Abstract #8106; Poster Board #R14; Lung Cancer - Metastatic, May 30, 2:00 p.m.-6:00 p.m.

Ready N, et al. AT-101 or placebo (P) with docetaxel (D) in second line NSCLC with ge
'/>"/>

SOURCE Ascenta Therapeutics
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Ascenta Therapeutics Announces Positive Preliminary Results with AT-101 in Docetaxel Refractory Prostate Cancer
2. Oxford BioTherapeutics and GlaxoSmithKline Form Strategic Alliance to Develop Novel Cancer Therapeutic Antibodies
3. FDA Accepts Arno Therapeutics IND for AR-12 a PDK1 Inhibitor That Blocks the PI3K/Akt Pathway
4. Logical Therapeutics Appoints Peter A. Lankau as CEO and Director
5. Arcion Therapeutics Topical Pain Candidate, ARC-4558, Significantly Reduces Pain Caused by Diabetic Neuropathy
6. Trius Therapeutics Announces Presentations Featuring Torezolid Antibiotic at the 19th European Congress of Clinical Microbiology and Infectious Diseases
7. Hyperion Therapeutics Receives Orphan Drug Designation for HPN-100 for the Treatment of Urea Cycle Disorders
8. Sirion Therapeutics Announces Clinical Data Presentations at the 2009 Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting
9. Intarcia Therapeutics, Inc. Announces Completion of Enrollment of ITCA 650 Phase 1b Study for the Treatment of Type 2 Diabetes
10. Hyperion Therapeutics Announces Results for Phase II Study in Urea Cycle Disorders
11. Amicus Therapeutics Announces Issuance of New Plicera(TM) Composition of Matter Patent
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/3/2015)... March 3, 2015 Actavis plc (NYSE: ... an offering of $21 billion aggregate principal amount of ... public offering to be issued by its indirect wholly-owned ... its other subsidiaries (the "Notes"), as follows: ... Senior Notes* , $500,000,000 , Due 2016 ...
(Date:3/3/2015)... Medical Tracking Solutions, Inc., developers of ... Brian Timberlake as Senior Vice President ... build relationships with existing and new clients. Brian brings ... and sales management as well as a deep ... comprehensive inventory management system that provides real-time tracking ...
(Date:3/3/2015)... , March 3, 2015 Boston Scientific Corporation ... Charles J. Dockendorff and Stephen P. MacMillan ... current members of the board, Uwe E. Reinhardt ... re-election at the company,s annual meeting of stockholders in May ... formerly the executive vice president and chief financial officer of ...
Breaking Medicine Technology:Actavis Announces Pricing of Public Offering of Senior Notes in Connection with Pending Acquisition of Allergan 2Actavis Announces Pricing of Public Offering of Senior Notes in Connection with Pending Acquisition of Allergan 3Actavis Announces Pricing of Public Offering of Senior Notes in Connection with Pending Acquisition of Allergan 4Actavis Announces Pricing of Public Offering of Senior Notes in Connection with Pending Acquisition of Allergan 5Actavis Announces Pricing of Public Offering of Senior Notes in Connection with Pending Acquisition of Allergan 6Actavis Announces Pricing of Public Offering of Senior Notes in Connection with Pending Acquisition of Allergan 7Actavis Announces Pricing of Public Offering of Senior Notes in Connection with Pending Acquisition of Allergan 8Actavis Announces Pricing of Public Offering of Senior Notes in Connection with Pending Acquisition of Allergan 9Actavis Announces Pricing of Public Offering of Senior Notes in Connection with Pending Acquisition of Allergan 10Medical Tracking Solutions, Inc. Hires New SVP, Sales 2Boston Scientific Elects Charles J. Dockendorff And Stephen P. MacMillan To Board Of Directors 2
... Inc. (Nasdaq: COLY ), today announced that ... from GlaxoSmithKline (GSK),associated with the initiation of GSK,s ... (NSCLC) of an immunotherapeutic cancer vaccine,containing Coley,s VaxImmune(TM) ... the launch of the largest Phase III,clinical trial ...
... 26 IDM Pharma, Inc.,(Nasdaq: IDMI ), ... cancer therapies, today announced details on clinical data,presentations ... be,presented at upcoming medical congresses. Specific presentation ... Connective Tissue Oncology Society (CTOS) -- Seattle, Wash. ...
Cached Medicine Technology:Coley Pharmaceutical Group Receives $3.0 Million Milestone Payment from GlaxoSmithKline 2Coley Pharmaceutical Group Receives $3.0 Million Milestone Payment from GlaxoSmithKline 3IDM Pharma Announces Upcoming Clinical Data Presentations 2IDM Pharma Announces Upcoming Clinical Data Presentations 3IDM Pharma Announces Upcoming Clinical Data Presentations 4
(Date:3/4/2015)... Hills Estates, CA (PRWEB) March 04, 2015 ... for clever dialogue and lyrical music, will be performed ... in Rolling Hills Estates, CA, this March 6-22, 2015, ... Performing Arts Center at Peninsula High School (27118 ... are available one hour before the program or may ...
(Date:3/4/2015)... RapidScale, a global cloud services innovator, is ... March 16th-18th. They are hosting Booth #1010 on the ... top engineering executives in attendance to provide demos and ... Attendees include William Hiatt, CTO; Jeff Richards, Cloud Delivery ... Cloud Support Manager. , RapidScale is also hosting ...
(Date:3/4/2015)... 04, 2015 Plungerhead has ... service members during and after their service to the ... increase awareness through advertising, social media and several national ... patriotic organization through a special retail promotion of Plungerhead ... March through May 2015. , “There is a ...
(Date:3/4/2015)... (PRWEB) March 04, 2015 Staff Sgt ... IED explosion in Iraq, tells you about the pain ... some free Chiropractic care from the Patriot Project and ... , This is what Harris said in a recent ... have clarity, I feel more calm, I'm sleeping better, ...
(Date:3/4/2015)... i2i Systems Population Health Management ... Brexton Health Care, a 35-year-old Maryland-based community health ... provides comprehensive primary care, behavioral health and dental ... clinics in the greater Baltimore area of Maryland. ... the organization has always focused on providing quality ...
Breaking Medicine News(10 mins):Health News:The New Mel Brooks Musical Young Frankenstein Performance March 6-March 22, 2015, by the Award Winning Drama Department at Peninsula High School, Rolling Hills 2Health News:Rapidscale to Host First Cloudtalk Events at Channel Partners in Las Vegas 2Health News:Rapidscale to Host First Cloudtalk Events at Channel Partners in Las Vegas 3Health News:Plungerhead Partners with the Boot Campaign to Benefit US Military Community 2Health News:Plungerhead Partners with the Boot Campaign to Benefit US Military Community 3Health News:Decorated Veterans Endorse “Halos for Heroes” an Indiegogo campaign to Help Wounded Military Heal at Home 2Health News:Decorated Veterans Endorse “Halos for Heroes” an Indiegogo campaign to Help Wounded Military Heal at Home 3Health News:Chase Brexton Selects i2i Systems Population Health Management Solutions to Demonstrate HEDIS Quality Outcomes to Maryland’s Health Plans 2Health News:Chase Brexton Selects i2i Systems Population Health Management Solutions to Demonstrate HEDIS Quality Outcomes to Maryland’s Health Plans 3
... , , WARRENDALE, Pa., July ... to be showcased at the Premier healthcare alliance ... suppliers that are committed to improving patient outcomes through product innovation. ... one of only 24 products showcased at the event. , ...
... vitamin B deficiency , FRIDAY, July 17 (HealthDay ... surgery helps patients lose weight faster and avoid vitamin ... the "good" bacteria found in yogurt and in dietary ... of Medicine study included 44 patients who had Roux-en-Y ...
... Companies ... of dollars, says Reed Group President, Guidelines, Jon Seymour, MD. , ... Westminster, CO (Vocus) July 16, 2009 -- Companies whose ... dollars, says Reed Group President, Guidelines, Jon Seymour , MD. , , ...
... July 17 Dr. Gabriel DeCandido, a physician practicing internal medicine ... million to settle allegations that he defrauded the Medicare program, the ... In a complaint filed in the United States District Court ... Michael Flanery v. Dr. Gabriel DeCandido, et al ., the United ...
... , ELM GROVE, Wis., July 17 ... Percentile Rankings Within 4 Months is the second in ... a hospital process improvement firm. With federal funding at risk, ... helping avoid common mistakes made by hospitals when working on programs ...
... , SANTA MONICA, Calif., July 17 ... critical thinking, created the new website www.prescriptiondrugs.procon.org ... advertised directly to consumers?" , , ... published on whether direct to consumer (DTC) prescription drug ads ...
Cached Medicine News:Health News:MEDRAD Recognized by the Premier Healthcare Alliance for Commitment to Healthcare Quality Improvement and Innovation 2Health News:MEDRAD Recognized by the Premier Healthcare Alliance for Commitment to Healthcare Quality Improvement and Innovation 3Health News:MEDRAD Recognized by the Premier Healthcare Alliance for Commitment to Healthcare Quality Improvement and Innovation 4Health News:Reed Group Will Debut New Predictive Modeling Tool at DMEC Conference 2Health News:Reed Group Will Debut New Predictive Modeling Tool at DMEC Conference 3Health News:Reed Group Will Debut New Predictive Modeling Tool at DMEC Conference 4Health News:Reed Group Will Debut New Predictive Modeling Tool at DMEC Conference 5Health News:Tampa Bay Doctor Agrees to Pay United States $1.7 Million to Resolve Medicare Fraud Allegations 2Health News:Compirion Healthcare Sponsors Webinar on 7 Mistakes That Lower Patient Satisfaction Scores 2Health News:Compirion Healthcare Sponsors Webinar on 7 Mistakes That Lower Patient Satisfaction Scores 3Health News:Debate Over Advertising Prescription Drugs to Consumers Goes Online at New ProCon.org Website 2
For use with Snap-In Snap-Out-II tip inserts. Available in five styles, the Snap-In Snap-Out-II Laparoscopic Instrument Handles offer the broadest range available....
Inquire...
The Snap-In Snap-Out-II Tip Inserts offer a large variety of configurations....
The Optima III line of laparoscopic hand instruments provides a well-crafted set of instruments designed for strength and durability....
Medicine Products: